Victory Square Technologies Inc. (“Victory Square”) (CSE:VST)
(OTC:VSQTF) (FWB:6F6), a company that gives investor access to a
portfolio of 25+ innovative companies from around the world in a
single stock, is pleased to share that its portfolio company -
Hydreight Technologies Inc. (“Hydreight” or the “Company”) ( TSXV:
NURS )( OTCQB: HYDTF )( FSE: SO6 ), a fast-growing mobile clinical
network and medical platform which enables flexible at-home medical
services across 50 states in the United States, is pleased to
announce a partnership formed with a National Laboratory to expand
its “At-Home Testing” Solution in all 50 States by Q4, 2024. This
partnership was finalized on July 9, 2024.
Subscribers and Nurses on Hydreight’s platform can start
offering at-home lab tests spanning a range of general wellness,
nutrition, heart health, blood sugar, sexual health, thyroid,
inflammation and will include chronic care management and drug
testing by the end of the year.
After ordering the test online and paying up front, a nurse
would come to the consumer's location to administer the test and
ship back the sample collection to the National Laboratory partner.
Within a few days, the consumer can access a breakdown of their
results in Hydreight’s app and for certain conditions may be
connected to virtual consultation services. Hydreight currently
offers all necessary blood tests for GLP-1, available and fully
integrated on its app.
At-home tests cover a broad spectrum of health concerns,
including:
- Blood Glucose (calculates blood sugar level)
- Lipid profile test (measures cholesterol and
triglycerides)
- Metabolic panel (monitors Kidney and Liver health)
- Thyroid Hormone test (Thyroid hormone production)
- Reactive protein test (measures inflammation in the body)
Shane Madden established Hydreight in 2018 with the goal of
creating a platform and solution to help with delivering healthcare
directly to people's homes. Motivated by his own experience of a
health issue that remained undiagnosed for months due to lengthy
test result wait times, numerous doctor visits, and high costs,
Madden sought to create a more efficient and accessible way to
address health concerns.
"Our mission is to empower individuals to lead longer, happier
lives by offering tools for managing health from home. We provide
direct access to diagnostic testing, virtual care, and medication
delivery for a broad spectrum of health and wellness conditions,"
Madden stated.
The U.S. diagnostic testing market size was valued at USD 84.85
billion in 2023 and is anticipated to reach around USD 158.77
billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.
The pandemic got consumers used to home-testing for COVID-19,
which resulted in a watershed moment for all aspects of
diagnostics. And now they're interested in doing additional at-home
diagnostics, for example, for vitamin and mineral deficiencies, gut
health, hormone and cholesterol. People now expect affordable,
high-quality, and easy diagnostic testing more than ever
before.
The diagnostic testing market in the US is thriving, with
diagnostic tests being a cornerstone of its healthcare system.
These tests, which analyze samples from the body, serve diverse
purposes across medical care stages, including prevention,
detection, diagnosis, treatment, and disease management. They
facilitate evidence-based medicine, enhance quality of care,
promote wellness, enable early disease detection, and contribute to
reducing overall healthcare costs.
"The pandemic highlighted the difficulties Americans face with
lab testing, including unclear costs, confusion, and inconvenience.
At Hydreight, we are providing a new approach to testing, and we
will continue to pioneer in this fast-growing field," stated Shane
Madden, CEO of Hydreight. "We envision a future where lab testing
is quick, straightforward, and integrated with virtual care,
allowing us to create a transformative, enduring digital health
company that prioritizes people – exactly where they should
be."
The home healthcare market is projected to reach $340B USDby
2027 in the US alone, and the Company is well positioned to
capitalize on the rapidly growing home healthcare industry and will
continue using our platform to empower healthcare professionals to
deliver personalized, on demand care bridging the gap between
provider compliance and patient convenience.
About Hydreight Technologies Inc.
Hydreight Technologies Inc. is building the largest mobile
clinic network in the United States. Its proprietary, fully
integrated platform hosts a network of over 2,500 nurses, over 100
doctors and a pharmacy network across 50 states. The platform
includes a built-in, easy-to-use suite of fully integrated tools
for accounting, documentation, sales, inventory, booking, and
managing patient data, which enables licensed healthcare
professionals to provide services directly to patients at home,
office or hotel. Hydreight is bridging the gap between provider
compliance and patient convenience, empowering nurses, med spa
technicians, and other licensed healthcare professionals. The
Hydreight platform allows healthcare professionals to deliver
services independently, on their own terms, or to add mobile
services to existing location-based operations. Hydreight though
its medical network has a 503B pharmacy network servicing all 50
states and is closely affiliated with a U.S. certified e-script and
telemedicine provider network that provides services in all 50
states.
Sign up to VST’s official newsletter at
www.VictorySquare.com/newsletter
On behalf of the Board of Directors
“Shafin Diamond Tejani”Director and Chief Executive
OfficerVictory Square Technologies Inc.www.victorysquare.com
For further information about Victory Square, please
contact:
Investor Relations Contact – Abbey VogtEmail:
ir@victorysquare.comTelephone: 604 283-9166
Peter Smyrniotis – DirectorTelephone: 604 283-9166
ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square is a Venture Builder that provides investors a
liquid way to invest in early-stage technology companies without
buying a venture fund that requires accredited investor status or
multi-year commitments.
- A diverse portfolio of 25+ innovative companies from around the
world (founders come from: Ireland, Sri Lanka, Bulgaria, Australia,
India, Brazil, the Middle East and North America)
- Sectors include: Digital Health, Artificial Intelligence (AI),
Machine Learning (ML), Blockchain/Web3, Virtual & Augmented
Reality (VR/AR), Gaming, Climate Tech
- Owner-operated (approx. 15% Management Ownership)
Business Model:
The Victory Square business model is to buy, build and invest in
early stage tech companies. We spend upwards of 48 months with
those companies until they're ready to spin-off or stand on their
own. There are a couple of unique elements to our business
model…
- We have unparalleled access to startups through our internal
incubator and International network with over 250+ founders,
investors, tech accelerators and venture capital firms from more
than 60 countries.
- Second, our management team and advisors are actively involved
in our investments from incubation through monetization, providing
them with financial, operational, and strategic support to scale
globally.
- We drive value by monetizing investments and reinvesting the
gains in new innovations. The strategy was to build a
self-sustaining business.
VST is a publicly-traded company headquartered in Vancouver,
Canada, and listed on the Canadian Securities Exchange (VST),
Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For more
information, please visit www.victorysquare.com.
ABOUT THE CANADIAN SECURITIES EXCHANGE
(CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX
Markets Inc. Recognized as a stock exchange in 2004, the CSE began
operations in 2003 to provide a modern and efficient alternative
for companies looking to access the Canadian public capital
markets.
FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within
the meaning of applicable securities laws relating to the outlook
of the business of Victory Square and its portfolio companies,
including, without limitation, statements relating to future
performance, execution of business strategy, future growth,
business prospects and opportunities of Victory Square and its
related subsidiaries and portfolio companies, including those items
listed under the heading “Net Asset Value (“NAV”) Update”, “Notable
Portfolio Highlights” and other factors beyond our control. Such
forward-looking statements may, without limitation, be preceded by,
followed by, or include words such as “believes”, “expects”, “to
be”, “anticipates”, “estimates”, “intends”, “plans”, “continues”,
“project”, “potential”, “possible”, “contemplate”, “seek”, “goal”,
“objectives”, “outlook” or similar expressions, or may employ such
future or conditional verbs as “may”, “might”, “will”, “could”,
“should” or “would”, or may otherwise be indicated as
forward-looking statements by grammatical construction, phrasing or
context. All statements other than statements of historical facts
contained in this news release are forward-looking statements.
Forward-looking information is based on certain key expectations
and assumptions made by the management of Victory Square. Although
Victory Square believes that the expectations and assumptions on
which such forward-looking information is based are reasonable,
undue reliance should not be placed on them because Victory Square
can give no assurance that they will prove to be correct. Although
Victory Square believes that the expectations reflected in
forward-looking statements in this press release are reasonable,
such forward-looking statements have been based on expectations,
factors and assumptions concerning future events which may prove to
be inaccurate and are subject to numerous risks and uncertainties,
certain of which are beyond the Victory Square’s control,
including, but not limited to, the risk factors discussed in the
continuous disclosure materials of the Victory Square which are
available under the Victory Square’s profile on SEDAR at
www.sedar.com. The forward-looking statements contained in this
press release are expressly qualified by this cautionary statement
and are made as of the date hereof. Actual results and developments
may differ materially from those contemplated by these statements.
The statements contained in this news release are made as of the
date of this news release. Victory Square disclaims any intent or
obligation to update publicly any forward-looking information,
whether as a result of new information, future events or results or
otherwise, other than as required by applicable securities
laws.
The Canadian Securities Exchange has neither approved nor
disapproved the contents of this news release and accepts no
responsibility for the adequacy or accuracy hereof.
Hydreight Technologies (TSXV:NURS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Hydreight Technologies (TSXV:NURS)
Historical Stock Chart
From Nov 2023 to Nov 2024